Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

NCT01349088 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: Ixabepilone
DRUG: Capecitabine
DRUG: Motesanib

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]
[object Object]